Skip to content

Clinical trials

Completed Fallopian Tube Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Completed Country / region: Russia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20132
20141
20161
20172
20181
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
pharmaand GmbH2
AbbVie1
Amgen1
Glycotope GmbH1
Hoffmann-La Roche1
ImmunoGen, Inc.1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms14
Ovarian Neoplasms11
Carcinoma, Ovarian Epithelial5
Peritoneal Neoplasms4
Genital Neoplasms, Male1
Neoplasms1
Prostatic Neoplasms1
Recurrence1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.